IFP Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Buy |
1,074
+948
| +752% | +$16.4K | ﹤0.01% | 2589 |
|
|
2025
Q1 | $2.76K | Sell |
126
-3,962
| -97% | -$86.6K | ﹤0.01% | 3040 |
|
|
2024
Q4 | $130K | Sell |
4,088
-93
| -2% | -$2.97K | ﹤0.01% | 1336 |
|
|
2024
Q3 | $121K | Sell |
4,181
-188
| -4% | -$5.42K | ﹤0.01% | 1324 |
|
|
2024
Q2 | $168K | Buy |
4,369
+671
| +18% | +$25.7K | 0.01% | 1124 |
|
|
2024
Q1 | $217K | Sell |
3,698
-31
| -0.8% | -$1.82K | 0.01% | 959 |
|
|
2023
Q4 | $223K | Sell |
3,729
-77
| -2% | -$4.61K | 0.01% | 901 |
|
|
2023
Q3 | $145K | Buy |
3,806
+1,862
| +96% | +$70.8K | 0.01% | 1110 |
|
|
2023
Q2 | $177K | Sell |
1,944
-41
| -2% | -$3.74K | 0.01% | 1078 |
|
|
2023
Q1 | $39K | Buy |
1,985
+1,981
| +49,525% | +$38.9K | ﹤0.01% | 1700 |
|
|
2022
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 4279 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 3365 |
|
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3075 |
|